Literature DB >> 23462501

Pandemic influenza in the 2009/2010 season in central Poland: the surveillance study of laboratory confirmed cases.

Ernest Kuchar1, Aneta Nitsch-Osuch, Teresa Karpinska, Donata Kurpas, Katarzyna Zycinska, Kazimierz Wardyn, Leszek Szenborn.   

Abstract

We retrospectively studied confirmed cases of influenza obligatorily reported to health authorities in central Poland during the 2009/2010 season. Each case was traced and examined with a questionnaire. The samples were tested for influenza A and B by RT-PCR. A total of 561 cases of influenza, including 185 in children under 14 years old, were detected. Four hundred and eighty four people were hospitalized, including 142 children under 14. Thirty two patients died, all with pre-existing risk factors. The most common complications were pneumonia, cardiac arrest, septic shock, circulatory insufficiency, multi-organ failure and myocarditis. The majority of patients (388/484) were treated with oseltamivir. Fifty three patients were mechanically ventilated, 52 patients were given oxygen. Only 11 out of the 561 patients were immunized against seasonal influenza. In conclusion, pandemic influenza affects all age groups, but it is more common in younger patients. Pandemic influenza is becoming an emerging health risk for the Polish population.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23462501     DOI: 10.1016/j.resp.2013.02.013

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

1.  Influenza SIRS with Minimal Pneumonitis.

Authors:  Shruti Erramilli; Praveen Mannam; Constantine A Manthous
Journal:  Front Med (Lausanne)       Date:  2016-08-31

Review 2.  Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections.

Authors:  E Kuchar; K Miśkiewicz; Aneta Nitsch-Osuch; L Szenborn
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.